Effects of a Short Course of Eszopiclone on Continuous Positive Airway Pressure Adherence: A Randomized Trial
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Background: Adherence to short-term continuous positive airway pressure (CPAP) may predict long-term use. Unfortunately, initial CPAP intolerance may lead to poor adherence or abandonment of therapy. Objective: To determine whether a short course of eszopiclone at the onset of therapy improves long-term CPAP adherence more than placebo in adults with obstructive sleep apnea. Design: Parallel randomized, placebo-controlled trial from March 2007 to December 2008. Randomization, maintained and concealed centrally by pharmacy personnel, was computer-generated using fixed blocks of 10. Referring physicians, investigators, and patients were blinded to the treatment assignment until after the final data were collected. (ClinicalTrials.gov registration number: NCT00612157) Setting: Academic sleep disorder center. Patients: 160 adults (mean age, 45.7 years [SD, 7.3]; mean apnea–hypopnea index, 36.9 events/h [SD, 23]) with newly diagnosed obstructive sleep apnea initiating CPAP. Intervention: Eszopiclone, 3 mg (n = 76), or matching placebo (n = 78) for the first 14 nights of CPAP. Measurements: Use of CPAP was measured weekly for 24 weeks. Adherence to CPAP (primary outcome) and the rate of CPAP discontinuation and improvements in symptoms (secondary outcomes) were compared. Follow-up at 1, 3, and 6 months was completed by 150, 136, and 120 patients, respectively. Results: Patients in the eszopiclone group used CPAP for 20.8% more nights (95% CI, 7.2% to 34.4%; P = 0.003), 1.3 more hours per night for all nights (CI, 0.4 to 2.2 hours; P = 0.005), and 1.1 more hours per night of CPAP use (CI, 0.2 to 2.1 hours; P = 0.019). The hazard ratio for discontinuation of CPAP was 1.90 (CI, 1.1 to 3.4; P = 0.033) times higher in the placebo group. Side effects were reported in 7.1% of patients and did not differ between groups. Limitations: Patients had severe obstructive sleep apnea treated at a specialized sleep center with frequent follow-up; results may not be generalizable to different settings. Patients' tolerance to CPAP and their reasons for discontinuation were not assessed. Conclusion: Compared with placebo, a short course of eszopiclone during the first 2 weeks of CPAP improved adherence and led to fewer patients discontinuing therapy. Primary Funding Source: Sepracor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CPAP treatment in some patients may lead to insomnia since the lowering of arousal threshold may be associated with worsening of sleep quality.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [419]
Citations
Cites
Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension
Peppard, P. E., Young, T., Palta, M., & Skatrud, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421901 · Cited by 4,973
Nieto, F. J. (2000) · JAMA · doi:10.1001/jama.283.14.1829 · Cited by 3,369
Kushida, C. A., Littner, M. R., Morgenthaler, T., Alessi, C. A., Bailey, D., Coleman, J., Friedman, L., Hirshkowitz, M., Kapen, S., Kramer, M., et al. (2005) · Sleep · doi:10.1093/sleep/28.4.499 · Cited by 2,054 · cited 1×
“We established the diagnosis and defined the severity of OSA in accordance with American Academy of Sleep Medicine criteria by using the apnea‐ hypopnea index ( 20 ).”
MethodAdherence to Continuous Positive Airway Pressure Therapy: The Challenge to Effective Treatment
Weaver, T. E., & Grunstein, R. R. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200708-119mg · Cited by 1,680
Daytime Sleepiness, Snoring, and Obstructive Sleep Apnea
Johns, M. W. (1993) · Chest · doi:10.1378/chest.103.1.30 · Cited by 1,119
An Instrument to Measure Functional Status Outcomes for Disorders of Excessive Sleepiness
(1997) · Sleep · doi:10.1093/sleep/20.10.835 · Cited by 881
Long-term Use of CPAP Therapy for Sleep Apnea/Hypopnea Syndrome
McARDLE, N., DEVEREUX, G., HEIDARNEJAD, H., ENGLEMAN, H. M., MACKAY, T. W., & DOUGLAS, N. J. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.4.9807111 · Cited by 820 · cited 1×
“Patients who experience initial discomfort, intolerance, or lack of perceived benefit are more likely to discontinue therapy (8).”
BackgroundNight-To-Night Variability in CPAP Use Over the First Three Months of Treatment
Weaver, T. E., Kribbs, N. B., Pack, A. I., Kline, L. R., Chugh, D. K., Maislin, G., Smith, P. L., Schwartz, A. R., Schubert, N. M., Gillen, K. A., et al. (1997) · Sleep · doi:10.1093/sleep/20.4.278 · Cited by 530 · cited 1×
“The average nightly CPAP use during the first 3 months of therapy can predict use at 6 and 12 months (12).”
BackgroundImproving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS)
Engleman, H. M., & Wild, M. R. (2003) · Sleep Medicine Reviews · doi:10.1053/smrv.2001.0197 · Cited by 473
Sleepiness, Sleep-disordered Breathing, and Accident Risk Factors in Commercial Vehicle Drivers
Howard, M. E., Desai, A. V., Grunstein, R. R., Hukins, C., Armstrong, J. G., Joffe, D., Swann, P., Campbell, D. A., & Pierce, R. J. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200312-1782oc · Cited by 468
Research works printed but not linked: 2
- Budhiraja R, 2007, Sleep, 30, 320
- Weaver TE, 1997, Sleep, 20, 835, 10.1093/sleep/20.4.278 · DOI · Paper page
Cited by
Adult obstructive sleep apnoea
Jordan, A. S., McSharry, D. G., & Malhotra, A. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60734-5 · Cited by 1,735
Sawyer, A. M., Gooneratne, N. S., Marcus, C. L., Ofer, D., Richards, K. C., & Weaver, T. E. (2011) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2011.01.003 · Cited by 900
Obstructive Sleep Apnea in Adults
Veasey, S. C., & Rosen, I. M. (2019) · New England Journal of Medicine · doi:10.1056/nejmcp1816152 · Cited by 615
Qaseem, A., Dallas, P., Owens, D. K., Starkey, M., Holty, J.-E. C., Shekelle, P., & for the Clinical Guidelines Committee of the American College of Physicians* (2014) · Annals of Internal Medicine · doi:10.7326/m12-3187 · Cited by 516
Updates on Definition, Consequences, and Management of Obstructive Sleep Apnea
Park, J. G., Ramar, K., & Olson, E. J. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0810 · Cited by 429
Metadata
- Authors
- Lettieri, C. J., Shah, A. A., Holley, A. B., Kelly, W. F., Chang, A. S., Roop, S. A., & Trial, F. T. C. A. (. P. A. P. A. S. A. P.
- Affiliations
- Uniformed Services University of the Health Sciences (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2009-11-17
- Volume
- 151
- Issue
- 10
- Pages
- 696-702
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1545440990
- Cited by
- 2
- References
- 33
- Citations by year
- 2020: 1 · 2015: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Keywords
- eszopiclone, continuous positive airway pressure, CPAP adherence, obstructive sleep apnea, CPAP intolerance, CPAP discontinuation, symptom improvement, CPAP side effects
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of a Short Course of Eszopiclone on Continuous Positive Airway Pressure Adherence: A Randomized Trial. https://app.cochat.ai/papers/10.7326/0003-4819-151-10-200911170-00006
- The paper
- Lettieri, C. J., Shah, A. A., Holley, A. B., Kelly, W. F., Chang, A. S., Roop, S. A., & Trial, F. T. C. A. (. P. A. P. A. S. A. P. (2009). Effects of a Short Course of Eszopiclone on Continuous Positive Airway Pressure Adherence: A Randomized Trial. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-151-10-200911170-00006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.